Liquid Handling System Market worth over $4.8bn by 2027

Liquid Handling System Market size is set to surpass USD 4.8 billion by 2027, according to a new research report by Global Market Insights Inc.
 

Growing technological advancements in liquid handling systems is among the key factors fueling the penetration of these products across various domains. The use of liquid handling systems for accurate and efficient liquid handling has surged due to the advent of novel techniques that play a vital role in research and clinical laboratories. Growing R&D programs and clinical trials across the globe are expected to be one of the major factors driving the market growth.
 

Growing technological advancements pertaining to automated liquid handling systems are anticipated to promote the market progression. Increasing competition among pharmaceutical companies to develop novel drugs is boosting the adoption of technologically advanced automated systems. Automated liquid handling systems are an important part of genomic and cancer research as it involves analysis and synthesis generally include dispensing of additional solutions. Hence, manufacturers are focused to introduce technically advanced automated liquid handling systems based on different technologies for dispensing without surface adhesion. These technologies comprise solenoid, piezoelectric, ultrasound, etc.
 

Moreover, in recent years, the major players in the liquid handling system market are continuously engaged in R&D investments to produce better automated pipetting systems. Continuous development in automated pipette sensors aids market leaders to provide high-value products and services to the end-users. Several companies emphasize on applying computer-controlled linear motion to an open-source affordable liquid handler for automated micropipetting used in next generation sequencing (NGS), DNA/RNA purification, etc.
 

Growing spending on R&D along with the introduction of novel drugs across the globe is predicted to stimulate the market expansion

The manual segment is projected to witness 6% growth rate through 2027 led by the decrease in the time period of sample processing that has led to the high acceptance rate amongst diagnostic centers, biotechnology companies, research institutes, etc. Pharmaceutical firms are actively involved in making significant investments in global drug R&D, primarily in the nations including the U.S., China, India, Germany, etc. The development of innovative manual liquid handling solutions improves clinical research by reducing the development cost and facilitate the rapid launch of drugs. Hence, pharmaceutical firms are focused towards the usage of innovative manual liquid handlers for quick drug approval with minimal investment.
 

Browse key industry insights spread across 175 pages with 292 market data tables & 17 figures & charts from the report, “Liquid Handling System Market Size By Device Type (Manual, Electronic, Automated), By Product (Pipettes {Manual Pipettes, Electronic Pipettes}, Dispensers, Burettes, Automated Workstation, Microplate Readers, Consumables), By Application (Drug Discovery, Clinical Diagnostics, Cancer and Genomics Research), By End-use (Diagnostic Centers, Research and Academic Institutes, Pharmaceutical & Biotechnology Industry), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/liquid-handling-systems-market
 

Increasing investment by the market participants to develop safe and effective automated workstations is estimated to attract a large customer pool

The automated workstation segment is projected to attain a CAGR of 7.4% by 2027 owing to the ability of automated workstations to offer several advantages in microbiology and cancer research laboratories such as to provide safer working conditions, avoid errors, reduce work pressure, etc. Currently, the automated workstations are gaining popularity primarily attributed to the surge in a number of biotech and research companies, development of health care infrastructure, shortage of trained laboratory professionals, advancements in clinical diagnostic laboratories, etc.
 

Rising awareness regarding the availability of medical and screening services for cancer treatment is expected to spur the liquid handling system market revenue

The cancer and genomics research segment is poised to expand at a CAGR of more than 6.6% through 2027 impelled by the rise in demand for personalized medicines, growing incidence of cancer, and the high potential of developing countries offering new opportunities for the market players. The governments of developed nations are focusing to conduct & implement programs for increasing awareness of screening tests including Digital Rectal Exam (DRE) and Prostate-Specific Antigen (PSA) blood tests for male patients above 50 years. In the coming years, prenatal genetic screening initiatives are anticipated to upsurge at a considerable rate. Furthermore, it is estimated that in the coming 10 years, all neonate’s genome would be sequenced and stored in the electronic medical record. Thus, the rising demand for oncology and genomic services attributed to their medical benefits is set to influence the industry growth.
 

Emerging number of diagnostic centers offering early disease diagnosis is projected to foster the market value

The diagnostic centers segment is poised to expand at more than 6.2% CAGR during 2021 to 2027 due to the rapidly surging elderly population and the subsequent upsurge in the prevalence of associated disorders, growing demand for early disease diagnosis, etc. As per the Centers for Disease Control and Prevention, around 85% of the older people in the U.S. suffer from at least one chronic condition. Additionally, according to the American Medical Association, around 60% of individuals aged 65 and above will be living with more than one chronic condition by 2030. This increasing prevalence rate is predicted to augment the demand for well-equipped diagnostic centers for precise disease management. Several countries in Europe are focusing on decentralizing their respective healthcare system to increase the efficiency of treatment and improve access to healthcare services at regional level for the early diagnosis of diseases.
 

Growing demand for advanced liquid handling systems in China is estimated to propel the market demand

China liquid handling system market size was over USD 310 million in 2020 owing to the increasing incidence of cancer, growing geriatric population, adoption of robotic automation, increasing R&D activities for drug development, favorable government regulations, etc. In 2017, the Chinese Food and Drugs Administration announced a series of policies enhancing regulatory standards and procedures for pharmaceutical products, particularly for rare conditions. In China, LabGeni, a supplier and manufacturer of laboratory instruments has designed a pipetting robot to reduce adding liquid errors and satisfy technical requirements in modern laboratories. In addition, the demand for liquid handling systems in China is expected to increase attributed to the growing pharmaceutical industry along with the acceptance of various strategies by market players including new product launches, collaborations, and acquisitions.
 

Companies are focusing on strategies and launch of innovative products to expand customer base

Some of the major participants operating in the market are Tecan Group Ltd., Hamilton Co., Eppendorf AG, Gilson Incorporated, Danaher Corporation, Thermo Fisher Scientific, Inc., Sartorius AG   , Aurora Biomed Inc., and Agilent Technologies, Inc. among others. These leaders are involved in partnerships, agreements, and acquisitions to gain an edge over their competitors.